The development of irreversible itk inhibitors as a potential new treatment for severe asthma

Sébastien André Campos, William Kerr, John D Harling, Angela M Deakin, Nick Barton, Dom Somers, Laiq Chaudry, Rachel Grimley, John William Barrett, Rebecca H Graves, Roberto Solari

Research output: Contribution to conferenceSpeech

Original languageEnglish
Publication statusPublished - 19 Nov 2014
EventSociety of Chemical Industry, Young Chemist In Industry 2014 - GlaxoSmithKline Medicines Research Centre, Stevenage, United Kingdom
Duration: 19 Nov 201419 Nov 2014

Conference

ConferenceSociety of Chemical Industry, Young Chemist In Industry 2014
CountryUnited Kingdom
CityStevenage
Period19/11/1419/11/14

Keywords

  • irreversible itk inhibitors
  • asthma treatment

Cite this

Campos, S. A., Kerr, W., Harling, J. D., Deakin, A. M., Barton, N., Somers, D., Chaudry, L., Grimley, R., Barrett, J. W., Graves, R. H., & Solari, R. (2014). The development of irreversible itk inhibitors as a potential new treatment for severe asthma. Society of Chemical Industry, Young Chemist In Industry 2014, Stevenage, United Kingdom.